AIMS: Our aim was to evaluate the performance of machine learning (ML), integrating clinical parameters with coronary artery calcium (CAC), and automated epicardial adipose tissue (EAT) quantification, for the prediction of long-term risk of myocardial infarction (MI) and cardiac death in asymptomatic subjects. METHODS AND RESULTS: Our study included 1912 asymptomatic subjects [1117 (58.4%) male, age: 55.8 ± 9.1 years] from the prospective EISNER trial with long-term follow-up after CAC scoring. EAT volume and density were quantified using a fully automated deep learning method. ML extreme gradient boosting was trained using clinical co-variates, plasma lipid panel measurements, risk factors, CAC, aortic calcium, and automated EAT measures, and validated using repeated 10-fold cross validation. During mean follow-up of 14.5 ± 2 years, 76 events of MI and/or cardiac death occurred. ML obtained a significantly higher AUC than atherosclerotic cardiovascular disease (ASCVD) risk and CAC score for predicting events (ML: 0.82; ASCVD: 0.77; CAC: 0.77, P < 0.05 for all). Subjects with a higher ML score (by Youden's index) had high hazard of suffering events (HR: 10.38, P < 0.001); the relationships persisted in multivariable analysis including ASCVD-risk and CAC measures (HR: 2.94, P = 0.005). Age, ASCVD-risk, and CAC were prognostically important for both genders. Systolic blood pressure was more important than cholesterol in women, and the opposite in men. CONCLUSIONS: In this prospective study, machine learning used to integrate clinical and quantitative imaging-based variables significantly improves prediction of MI and cardiac death compared with standard clinical risk assessment. Following further validation, such a personalized paradigm could potentially be used to improve cardiovascular risk assessment. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Our aim was to evaluate the performance of machine learning (ML), integrating clinical parameters with coronary artery calcium (CAC), and automated epicardial adipose tissue (EAT) quantification, for the prediction of long-term risk of myocardial infarction (MI) and cardiac death in asymptomatic subjects. METHODS AND RESULTS: Our study included 1912 asymptomatic subjects [1117 (58.4%) male, age: 55.8 ± 9.1 years] from the prospective EISNER trial with long-term follow-up after CAC scoring. EAT volume and density were quantified using a fully automated deep learning method. ML extreme gradient boosting was trained using clinical co-variates, plasma lipid panel measurements, risk factors, CAC, aortic calcium, and automated EAT measures, and validated using repeated 10-fold cross validation. During mean follow-up of 14.5 ± 2 years, 76 events of MI and/or cardiac death occurred. ML obtained a significantly higher AUC than atherosclerotic cardiovascular disease (ASCVD) risk and CAC score for predicting events (ML: 0.82; ASCVD: 0.77; CAC: 0.77, P < 0.05 for all). Subjects with a higher ML score (by Youden's index) had high hazard of suffering events (HR: 10.38, P < 0.001); the relationships persisted in multivariable analysis including ASCVD-risk and CAC measures (HR: 2.94, P = 0.005). Age, ASCVD-risk, and CAC were prognostically important for both genders. Systolic blood pressure was more important than cholesterol in women, and the opposite in men. CONCLUSIONS: In this prospective study, machine learning used to integrate clinical and quantitative imaging-based variables significantly improves prediction of MI and cardiac death compared with standard clinical risk assessment. Following further validation, such a personalized paradigm could potentially be used to improve cardiovascular risk assessment. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Balaji Tamarappoo; Damini Dey; Haim Shmilovich; Ryo Nakazato; Heidi Gransar; Victor Y Cheng; John D Friedman; Sean W Hayes; Louise E J Thomson; Piotr J Slomka; Alan Rozanski; Daniel S Berman Journal: JACC Cardiovasc Imaging Date: 2010-11
Authors: Daniel S Berman; Rory Hachamovitch; Leslee J Shaw; John D Friedman; Sean W Hayes; Louise E J Thomson; David S Fieno; Guido Germano; Nathan D Wong; Xingping Kang; Alan Rozanski Journal: J Nucl Med Date: 2006-07 Impact factor: 10.057
Authors: Markus Goeller; Stephan Achenbach; Mohamed Marwan; Mhairi K Doris; Sebastien Cadet; Frederic Commandeur; Xi Chen; Piotr J Slomka; Heidi Gransar; J Jane Cao; Nathan D Wong; Moritz H Albrecht; Alan Rozanski; Balaji K Tamarappoo; Daniel S Berman; Damini Dey Journal: J Cardiovasc Comput Tomogr Date: 2017-11-24
Authors: Alan Rozanski; Heidi Gransar; Leslee J Shaw; Johanna Kim; Lisa Miranda-Peats; Nathan D Wong; Jamal S Rana; Raza Orakzai; Sean W Hayes; John D Friedman; Louise E J Thomson; Donna Polk; James Min; Matthew J Budoff; Daniel S Berman Journal: J Am Coll Cardiol Date: 2011-04-12 Impact factor: 24.094
Authors: Michael J LaMonte; Shannon J FitzGerald; Timothy S Church; Carolyn E Barlow; Nina B Radford; Benjamin D Levine; John J Pippin; Larry W Gibbons; Steven N Blair; Milton Z Nichaman Journal: Am J Epidemiol Date: 2005-08-02 Impact factor: 4.897
Authors: George T Kondos; Julie Anne Hoff; Alexander Sevrukov; Martha L Daviglus; Daniel B Garside; Stephen S Devries; Eva V Chomka; Kiang Liu Journal: Circulation Date: 2003-05-12 Impact factor: 29.690
Authors: Frederic Commandeur; Markus Goeller; Julian Betancur; Sebastien Cadet; Mhairi Doris; Xi Chen; Daniel S Berman; Piotr J Slomka; Balaji K Tamarappoo; Damini Dey Journal: IEEE Trans Med Imaging Date: 2018-02-09 Impact factor: 10.048
Authors: Andrew Lin; Márton Kolossváry; Manish Motwani; Ivana Išgum; Pál Maurovich-Horvat; Piotr J Slomka; Damini Dey Journal: Radiol Cardiothorac Imaging Date: 2021-02-25
Authors: Andrew Lin; Márton Kolossváry; Jeremy Yuvaraj; Sebastien Cadet; Priscilla A McElhinney; Cathy Jiang; Nitesh Nerlekar; Stephen J Nicholls; Piotr J Slomka; Pál Maurovich-Horvat; Dennis T L Wong; Damini Dey Journal: JACC Cardiovasc Imaging Date: 2020-08-26
Authors: Balaji K Tamarappoo; Andrew Lin; Frederic Commandeur; Priscilla A McElhinney; Sebastien Cadet; Markus Goeller; Aryabod Razipour; Xi Chen; Heidi Gransar; Stephanie Cantu; Robert Jh Miller; Stephan Achenbach; John Friedman; Sean Hayes; Louise Thomson; Nathan D Wong; Alan Rozanski; Piotr J Slomka; Daniel S Berman; Damini Dey Journal: Atherosclerosis Date: 2020-11-13 Impact factor: 5.162
Authors: Jacek Kwiecinski; Evangelos Tzolos; Mohammed N Meah; Sebastien Cadet; Philip D Adamson; Kajetan Grodecki; Nikhil V Joshi; Alastair J Moss; Michelle C Williams; Edwin J R van Beek; Daniel S Berman; David E Newby; Damini Dey; Marc R Dweck; Piotr J Slomka Journal: J Nucl Med Date: 2021-04-23 Impact factor: 11.082
Authors: John Harry Caufield; Dibakar Sigdel; John Fu; Howard Choi; Vladimir Guevara-Gonzalez; Ding Wang; Peipei Ping Journal: Cardiovasc Res Date: 2022-02-21 Impact factor: 13.081
Authors: Andrew Lin; Márton Kolossváry; Ivana Išgum; Pál Maurovich-Horvat; Piotr J Slomka; Damini Dey Journal: Expert Rev Med Devices Date: 2020-06-16 Impact factor: 3.166
Authors: Cvetan Trpkov; Alexei Savtchenko; Zhiying Liang; Patrick Feng; Danielle A Southern; Stephen B Wilton; Matthew T James; Erin Feil; Ilias Mylonas; Robert J H Miller Journal: Int J Cardiol Heart Vasc Date: 2021-06-19